Search
Close this search box.

What the Trials Have Taught Us About Glycaemic vs eGFR Control When Using SGLT2 Inhibitors

What the Trials Have Taught Us About Glycaemic vs eGFR Control When Using SGLT2 Inhibitors

What the Trials Have Taught Us About Glycaemic vs eGFR Control When Using SGLT2 Inhibitors

Speakers: Professor Jonathan Shaw, A/Professor Elif Ekinci, Professor Toby Coates AO and A/Professor Peter MountDate: 4 November 2021


Webinar Search

Webinar Categories

Disclaimer: This webpage including the open access webinars is intended for use by healthcare professionals only. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.

ADS Professional Education Webinars

Disclaimer Notice

By agreeing to this disclaimer notice; you acknowledge that you are a registered healthcare professional accessing the open access clinical educational webinars hosted by the Australian Diabetes Society. The presentations and its content cannot be reproduced, copied or provided to other third parties. Please contact the Australian Diabetes Society via email admin@diabetessociety.com.au for any enquiries.